DKBmed Radio

Share

cover art for UPDATE 3/17/2021 - Q&A

3/17/2021

UPDATE 3/17/2021 - Q&A

Dr. Paul Auwaerter answers your COVID-19 questions. Topics: *Length of protection of native immunity vs. vaccination *Safety of air travel after two dose vaccination *Evaluating the AstraZeneca vaccine *Utilization of monoclonal antibodies and efficacy against variants *New developments in treatments for mild to moderate COVID-19 *Annual COVID-19 vaccination?

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-17-21-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty

Presenting faculty:

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

More Episodes

VIEW ALL

6/18/2021 - Improving Health Equity

Drs.Charles Vega andAima A.Ahonkhadiscussways we can address the COVID-19 health outcome disparities. Topics:Real COVID-19 patient storiesCOVID-19 health outcomes based on ethnicity and socioeconomic statusHow social determinants of health determine COVID-19 riskTreating hospitalized and ambulatory patientsPost-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-18-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Charles Vega, MD, FAAFPHealth Sciences Clinical ProfessorUC Irvine Department of Family MedicineAssistant Dean for Culture and Community EducationUC Irvine School of MedicineDirector, UC Irvine Program in Medical Education for the Latino CommunityIrvine, CAAima A.Ahonkhai, MD, MPHAssistant Professor of MedicineDivision of Infectious DiseasesVanderbilt University Medical Center

6/16/2021 - COVID-19 Vaccine Trials Part 1

Dr. Paul Auwaerter interviews Dr. Patrick Flume about COVID-19 vaccine trials. Topics: *Vaccine trial goals: preventing symptomatic COVID-19 vs preventing infection *Issues with comparing vaccine trials *The importance of recruiting a representative population (age, sex, race and ethnicity) *What do we know about vaccine safety for immunocompromised people?Post-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-11-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of MedicinePatrick Flume, MDProfessor of Medicine and Pediatrics, The Medical University of South CarolinaPowers-Huggins Endowed Chair for Cystic Fibrosis in Charleston, South Carolina

6/9/2021 - In the Pipeline Therapeutics

6/9/2021 - COVID-19: In the Pipeline TherapeuticsIn this on-demand video webinar, Dr. Paul Auwaerter discusses potential COVID-19 treatments currently in the pipeline. Topics: *Outpatient treatments: inhaled remdesivir, oral antivirals, inhaled budesonide, and monoclonal antibodies *Inpatient treatments:lenzilumab,baricitinib, and dexamethasone *Clinical progression, risk factors, and home care for COVID-19 patientsPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/6-9-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresenting faculty: Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine at Johns Hopkins University School of Medicine